2-Benzofurancarboxaldehyde
| Common Name: |
2-Benzofurancarboxaldehyde |
| IUPAC Name: |
1-benzofuran-2-carbaldehyde |
| Molecular Formula: |
C9H6O2 |
| SMILES: |
C1=CC=C2C(=C1)C=C(O2)C=O |
| Inchi: |
1S/C9H6O2/c10-6-8-5-7-3-1-2-4-9(7)11-8/h1-6H |
| Inchi Key: |
ADDZHRRCUWNSCS-UHFFFAOYSA-N |
| Cas No: |
4265-16-1 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
2 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
146.14 |
| Mass (g/mol) |
146.037 |
| Molar Refractivity |
41.60 |
| Net Charge |
|
| HBD |
|
| HBA |
2 |
| Rt Bonds |
1 |
| Rings |
2 |
| TPSA |
30.21 |
| Hetero Atoms |
2 |
| Heavy Atoms |
11 |
| Aromatic Heavy Atoms |
9 |
| Melting Point (°C) |
195.00 to 198.00 |
| Boiling Point (°C@760.00mm Hg) |
135.00 @ 18.00 mm Hg |
| Vapor Pressure (mmHg@25.00 °C) |
0.02 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.00 |
| LogP |
2.245 |
| iLOGP |
1.49 |
| XLOGP3 |
2.35 |
| WLOGP |
2.25 |
| MLOGP |
0.88 |
| ESOL Log S |
-2.77 |
| ESOL Solubility (mg/ml) |
0.25 |
| ESOL Solubility (mol/l) |
0.002 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-2.62 |
| Ali Solubility (mg/ml) |
0.35 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-3.21 |
| Silicos-IT Solubility (mg/ml) |
0.09 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-5.52 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.897 |
| CYP1A2 Inhibitor |
1 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
1 |
| Acute Oral Toxicity |
2.22 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Warning |
| Eye Irritation |
1 |
| Hepatotoxicity |
1 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
